135 related articles for article (PubMed ID: 20172623)
1. Drug samples in dermatology: special considerations and recommendations for the future.
Alikhan A; Sockolov M; Brodell RT; Feldman SR
J Am Acad Dermatol; 2010 Jun; 62(6):1053-61. PubMed ID: 20172623
[TBL] [Abstract][Full Text] [Related]
2. Drug sampling in dermatology.
Reid EE; Alikhan A; Brodell RT
Clin Dermatol; 2012; 30(2):192-201. PubMed ID: 22330663
[TBL] [Abstract][Full Text] [Related]
3. Individual drug sampling does not supplant the need for head-to-head trials in dermatology.
Resneck JS; Vanbeek M
J Am Acad Dermatol; 2010 Jun; 62(6):1062-3. PubMed ID: 20172624
[TBL] [Abstract][Full Text] [Related]
4. Perceptions of the influence of prescription medicine samples on prescribing by family physicians.
Hall KB; Tett SE; Nissen LM
Med Care; 2006 Apr; 44(4):383-7. PubMed ID: 16565641
[TBL] [Abstract][Full Text] [Related]
5. Adherence in dermatology: a review of the last 20 years.
Hodari KT; Nanton JR; Carroll CL; Feldman SR; Balkrishnan R
J Dermatolog Treat; 2006; 17(3):136-42. PubMed ID: 16854752
[TBL] [Abstract][Full Text] [Related]
6. Patient safety in dermatology: a review of the literature.
Cao LY; Taylor JS; Vidimos A
Dermatol Online J; 2010 Jan; 16(1):3. PubMed ID: 20137745
[TBL] [Abstract][Full Text] [Related]
7. The rise of the generic drug market and its implications for dermatology.
Bhosle M; Balkrishnan R; Dewan T; Yelverton CB; Feldman SR
J Dermatolog Treat; 2005; 16(5-6):295-8. PubMed ID: 16428148
[TBL] [Abstract][Full Text] [Related]
8. Perception of prescription medicine sample packs among Australian professional, government, industry, and consumer organizations, based on automated textual analysis of one-on-one interviews.
Kyle GJ; Nissen L; Tett S
Clin Ther; 2008 Dec; 30(12):2461-73. PubMed ID: 19167604
[TBL] [Abstract][Full Text] [Related]
9. Global gene mining and the pharmaceutical industry.
Knudsen LE
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):679-83. PubMed ID: 15979678
[TBL] [Abstract][Full Text] [Related]
10. The economics of pediatric formulation development for off-patent drugs.
Milne CP; Bruss JB
Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
[TBL] [Abstract][Full Text] [Related]
11. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.
Wofford JL; Ohl CA
BMC Med Educ; 2005 Feb; 5(1):5. PubMed ID: 15698480
[TBL] [Abstract][Full Text] [Related]
12. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
Cowden AL; Katz KA
Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
[TBL] [Abstract][Full Text] [Related]
13. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
[TBL] [Abstract][Full Text] [Related]
14. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
Hodges B
CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153
[TBL] [Abstract][Full Text] [Related]
15. Key opinion leaders: where they come from and how that affects the drugs you prescribe.
Meffert JJ
Dermatol Ther; 2009; 22(3):262-8. PubMed ID: 19453351
[TBL] [Abstract][Full Text] [Related]
16. Nurse-led care in dermatology: a review of the literature.
Courtenay M; Carey N
Br J Dermatol; 2006 Jan; 154(1):1-6. PubMed ID: 16403087
[TBL] [Abstract][Full Text] [Related]
17. The value of pharmaceutical representative visits and medication samples in community-based family practices.
Backer EL; Lebsack JA; Van Tonder RJ; Crabtree BF
J Fam Pract; 2000 Sep; 49(9):811-6. PubMed ID: 11032205
[TBL] [Abstract][Full Text] [Related]
18. Ethics education for dermatology residents.
Bercovitch L; Long TP
Clin Dermatol; 2009; 27(4):405-10. PubMed ID: 19539170
[TBL] [Abstract][Full Text] [Related]
19. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
20. Google Scholar versus PubMed in locating primary literature to answer drug-related questions.
Freeman MK; Lauderdale SA; Kendrach MG; Woolley TW
Ann Pharmacother; 2009 Mar; 43(3):478-84. PubMed ID: 19261965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
